Literature DB >> 22323559

Association of major histocompatibility complex class 1 chain-related gene a dimorphism with type 1 diabetes and latent autoimmune diabetes in adults in the Algerian population.

Rachida Raache1, Khadidja Belanteur, Habiba Amroun, Amel Benyahia, Amel Heniche, Malha Azzouz, Safia Mimouni, Thibaud Gervais, Dominique Latinne, Aissa Boudiba, Nabila Attal, Mohamed Cherif Abbadi.   

Abstract

Major histocompatibility complex class I chain-related gene A (MICA-129) dimorphism was investigated in 73 autoimmune diabetes patients (type 1 diabetes and latent autoimmune diabetes in adults) and 75 controls from Algeria. Only MICA-129 Val allele and MICA-129 Val/Val genotype frequencies were higher among patients than in the control group. Statistical analysis of the estimated extended HLA-DR-DQ-MICA haplotypes shown that individual effects of MICA alleles on HLA-DQ2-DR3-MICA-129 Val/Val and HLA-DQ8-DR4-MICA-129 Val/Val haplotypes were significantly higher in patients than in the control groups. These preliminary data might suggest a relevant role of MICA-129 Val/Val single nucleotide polymorphism (weak/weak binders of NKG2D receptor) in the pathogenesis of T1D and LADA.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22323559      PMCID: PMC3318287          DOI: 10.1128/CVI.05473-11

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  41 in total

1.  Introduction: MICA/MICB in innate immunity, adaptive immunity, autoimmunity, cancer, and in the immune response to transplants.

Authors:  Peter Stastny
Journal:  Hum Immunol       Date:  2006-04-17       Impact factor: 2.850

2.  Triplet repeat polymorphism in the transmembrane region of the MICA gene: a strong association of six GCT repetitions with Behçet disease.

Authors:  N Mizuki; M Ota; M Kimura; S Ohno; H Ando; Y Katsuyama; M Yamazaki; K Watanabe; K Goto; S Nakamura; S Bahram; H Inoko
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-18       Impact factor: 11.205

3.  MICA is associated with type 1 diabetes in the Belgian population, independent of HLA-DQ.

Authors:  Jan E Van Autreve; Bobby P C Koeleman; Erik Quartier; Folefac Aminkeng; Ilse Weets; Frans K Gorus; Bart J R Van der Auwera
Journal:  Hum Immunol       Date:  2006-03-31       Impact factor: 2.850

Review 4.  How NKG2D ligands trigger autoimmunity?

Authors:  Sophie Caillat-Zucman
Journal:  Hum Immunol       Date:  2006-03-31       Impact factor: 2.850

Review 5.  Genes influencing innate and acquired immunity in type 1 diabetes and latent autoimmune diabetes in adults.

Authors:  Carani B Sanjeevi
Journal:  Ann N Y Acad Sci       Date:  2006-10       Impact factor: 5.691

6.  MICA marks additional risk factors for Type 1 diabetes on extended HLA haplotypes: an association and meta-analysis.

Authors:  Behrooz Z Alizadeh; Peter Eerligh; Arno R van der Slik; Arun Shastry; Alexandra Zhernakova; Gustavo Valdigem; Jan G Bruining; Carani B Sanjeevi; Cisca Wijmenga; Bart O Roep; Bobby P C Koeleman
Journal:  Mol Immunol       Date:  2007-03-12       Impact factor: 4.407

7.  Early-onset ankylosing spondylitis is associated with a functional MICA polymorphism.

Authors:  Habiba Amroun; Hachemi Djoudi; Marc Busson; Rachida Allat; Shérif Mohsen El Sherbini; Ivan Sloma; Rajendranath Ramasawmy; Manuel Brun; Nicolas Dulphy; Rajagopal Krishnamoorthy; Antoine Toubert; Dominique Charron; Mohamed Chérif Abbadi; Ryad Tamouza
Journal:  Hum Immunol       Date:  2005-11-02       Impact factor: 2.850

8.  MICA, a new polymorphic HLA-related antigen, is expressed mainly by keratinocytes, endothelial cells, and monocytes.

Authors:  N W Zwirner; M A Fernández-Viña; P Stastny
Journal:  Immunogenetics       Date:  1998       Impact factor: 2.846

Review 9.  Type 1 diabetes as a relapsing-remitting disease?

Authors:  Matthias von Herrath; Srinath Sanda; Kevan Herold
Journal:  Nat Rev Immunol       Date:  2007-12       Impact factor: 53.106

10.  MICA gene polymorphism in the pathogenesis of type 1 diabetes.

Authors:  G Gambelunghe; A Brozzetti; M Ghaderi; P Candeloro; C Tortoioli; A Falorni
Journal:  Ann N Y Acad Sci       Date:  2007-09       Impact factor: 5.691

View more
  10 in total

Review 1.  MICA SNPs and the NKG2D system in virus-induced HCC.

Authors:  Kaku Goto; Naoya Kato
Journal:  J Gastroenterol       Date:  2014-10-01       Impact factor: 7.527

Review 2.  Innate immunity in latent autoimmune diabetes in adults.

Authors:  Juan Huang; James Alexander Pearson; F Susan Wong; Li Wen; Zhiguang Zhou
Journal:  Diabetes Metab Res Rev       Date:  2021-06-22       Impact factor: 4.876

3.  The MICA-129 dimorphism affects NKG2D signaling and outcome of hematopoietic stem cell transplantation.

Authors:  Antje Isernhagen; Dörthe Malzahn; Elena Viktorova; Leslie Elsner; Sebastian Monecke; Frederike von Bonin; Markus Kilisch; Janne Marieke Wermuth; Neele Walther; Yesilda Balavarca; Christiane Stahl-Hennig; Michael Engelke; Lutz Walter; Heike Bickeböller; Dieter Kube; Gerald Wulf; Ralf Dressel
Journal:  EMBO Mol Med       Date:  2015-11       Impact factor: 12.137

Review 4.  Impact of the MICA-129Met/Val Dimorphism on NKG2D-Mediated Biological Functions and Disease Risks.

Authors:  Antje Isernhagen; Dörthe Malzahn; Heike Bickeböller; Ralf Dressel
Journal:  Front Immunol       Date:  2016-12-12       Impact factor: 7.561

Review 5.  Role of major histocompatibility complex variation in graft-versus-host disease after hematopoietic cell transplantation.

Authors:  Effie W Petersdorf
Journal:  F1000Res       Date:  2017-05-03

Review 6.  Major Histocompatibility Complex Class I Chain-Related A (MICA) Molecules: Relevance in Solid Organ Transplantation.

Authors:  Ajay Kumar Baranwal; Narinder K Mehra
Journal:  Front Immunol       Date:  2017-02-28       Impact factor: 7.561

7.  The association of HLA-G polymorphisms and the synergistic effect of sMICA and sHLA-G with chronic kidney disease and allograft acceptance.

Authors:  Vanessa Hauer; Matilde Risti; Bruna L M Miranda; José S da Silva; Ana L Cidral; Carolina M Pozzi; Fabiana L de C Contieri; Ibrahim A Sadissou; Eduardo A Donadi; Danillo G Augusto; Maria da G Bicalho
Journal:  PLoS One       Date:  2019-02-22       Impact factor: 3.240

8.  Association of MICA-129Met/Val polymorphism with clinical outcome of anti-TNF therapy and MICA serum levels in patients with rheumatoid arthritis.

Authors:  Milena Iwaszko; Jerzy Świerkot; Marta Dratwa; Barbara Wysoczańska; Lucyna Korman; Bartosz Bugaj; Katarzyna Kolossa; Sławomir Jeka; Piotr Wiland; Katarzyna Bogunia-Kubik
Journal:  Pharmacogenomics J       Date:  2020-03-03       Impact factor: 3.550

9.  The MICA-129Met/Val dimorphism affects plasma membrane expression and shedding of the NKG2D ligand MICA.

Authors:  Antje Isernhagen; Daniela Schilling; Sebastian Monecke; Pranali Shah; Leslie Elsner; Lutz Walter; Gabriele Multhoff; Ralf Dressel
Journal:  Immunogenetics       Date:  2015-11-19       Impact factor: 2.846

Review 10.  The Biological Influence and Clinical Relevance of Polymorphism Within the NKG2D Ligands.

Authors:  Jianmin Zuo; Fiyaz Mohammed; Paul Moss
Journal:  Front Immunol       Date:  2018-08-16       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.